Lonza Group announced Monday morning that Pierre-Alain Ruffieux will leave his post as CEO at the end of the month. Ruffieux, a former Roche executive, joined Lonza in 2020 and oversaw the company’s ...

Lone Star has entered into a definitive agreement to acquire the Capsules and Health Ingredients division of Lonza Group. Lonza will retain a 40 percent equity position in the business.

BOSTON & BASEL, Switzerland--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Lonza (SIX: LONN) today announced a strategic collaboration to support the manufacture of Vertex’s ...

The subdued stock price reaction suggests that Lonza Group AG's (VTX:LONN) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

Wednesday, Roche Holding AG (OTC:RHHBY) entered into a definitive agreement with Lonza Group Ltd (OTC:LZAGF) (OTC:LZAGY). Under the agreement, Lonza will acquire the Genentech manufacturing facility ...

Swiss contract development and manufacturing organisation (CDMO) Lonza Group AG plans to set up a global capability centre in Hyderabad as it expands its global operations support network. The move ...

Read Lonza Group AG (LZAGF) H1 FY2025 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...

-- New Agreement to Establish Global Commercial Manufacturing Capacity for Vaxcyte's (PCVX) PCV Candidates, VAX-24 and VAX-31, in Adult and Pediatric Populations -- -- Expanded Collaboration Builds on ...

Swiss Contract Service Provider Lonza Exits Capsules Business To Focus On Drug Development Lonza unveils its "One Lonza" strategy, highlighting a new structure to streamline operations, strengthen ...

Lonza America Inc is a subsidiary of Lonza Group, a Swiss multinational company that provides products and services to the pharmaceutical, biotech, and specialty ingredients markets. Lonza America Inc ...

Lonza Group agreed to buy InterHealth Nutraceuticals of Benicia for as much as $300 million, a sign the Swiss chemical maker may be back on the hunt for major acquisitions after a break of almost five ...